Daily Stock Analysis, MASI, Masimo Corp, priceseries

Masimo Corp. Daily Stock Analysis
Stock Information
Open
149.51
Close
144.32
High
150.75
Low
143.10
Previous Close
149.57
Daily Price Gain
-5.25
YTD High
291.15
YTD High Date
Jan 3, 2022
YTD Low
133.94
YTD Low Date
Feb 16, 2022
YTD Price Change
-140.55
YTD Gain
-49.34%
52 Week High
305.21
52 Week High Date
Nov 19, 2021
52 Week Low
133.94
52 Week Low Date
Feb 16, 2022
52 Week Price Change
-80.31
52 Week Gain
-35.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 6. 2016
62.98
Mar 16. 2017
93.31
68 Trading Days
48.15%
Link
LONG
Apr 19. 2017
94.89
May 4. 2017
100.17
11 Trading Days
5.57%
Link
LONG
Apr 16. 2018
86.73
May 15. 2018
96.42
21 Trading Days
11.17%
Link
LONG
Jan 8. 2019
105.94
Feb 26. 2019
127.09
33 Trading Days
19.96%
Link
LONG
Apr 22. 2020
200.95
May 21. 2020
243.32
21 Trading Days
21.09%
Link
LONG
Jun 10. 2021
218.63
Jul 26. 2021
266.41
31 Trading Days
21.85%
Link
Company Information
Stock Symbol
MASI
Exchange
NasdaqGS
Company URL
http://www.masimo.com
Company Phone
949-297-7000
CEO
Joe E. Kiani
Headquarters
California
Business Address
52 DISCOVERY, IRVINE, CA 92618
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000937556
About

Masimo Corp. develops and manufactures noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. It invents noninvasive technologies that are revolutionizing patient monitoring, including Masimo SET pulse oximetry, Masimo rainbow SET Pulse CO-Oximetry and new Masimo noninvasive and continuous total hemoglobin monitoring technology. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Description

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.